Señales en vivo de 002620.KS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 02:30):

Stats
Volumen de hoy	553 228
Volumen promedio	43 628.00
Capitalización de mercado	168.86B
EPS	KRW0 ( 2024-02-20 )
Próxima fecha de ganancias	( KRW0 ) 2024-05-10
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW21.73 (0.20%)

Volumen Correlación

Largo: 0.26 (neutral)

Corto: -0.21 (neutral)

Signal:(51.966) Neutral

Jeil Pharma Holdings Inc Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Jeil Pharma Holdings Inc Correlación - Moneda/Commodity

0.76
( moderate )

0.61
( weak )

0.73
( moderate )

-0.20
( neutral )

-0.48
( neutral )

Jeil Pharma Holdings Inc Finanzas

Annual	2023
Ingresos:	KRW794.71B
Beneficio Bruto:	KRW201.82B (25.40 %)
EPS:	KRW-1 058.54

FY	2023
Ingresos:	KRW794.71B
Beneficio Bruto:	KRW201.82B (25.40 %)
EPS:	KRW-1 058.54

FY	2022
Ingresos:	KRW792.96B
Beneficio Bruto:	KRW180.48B (22.76 %)
EPS:	KRW-5 416.22

FY	2021
Ingresos:	KRW762.57B
Beneficio Bruto:	KRW180.51B (23.67 %)
EPS:	KRW-226.85

Financial Reports:

No articles found.

Jeil Pharma Holdings Inc

Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives. The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. Jeil Pharma Holdings Inc was founded in 1959 and is headquartered in Seoul, South Korea.

Actualizaciones en tiempo real para Jeil Pharma Holdings Inc [002620.KS]

Upcoming Earnings Alert